
Norberto Bilbeny, M.D., Garbil Pharma Investigación Chile, Santiago, Chile Selfa Contreras, Pharm.D., Garbil Pharma Investigación Chile, Santiago, Chile Randall L. Davis, Ph.D., Neuroinflammation Research Laboratory, Department of Pharmacology/Physiology, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA Nicholas Floreani, B.S., Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA María Font, Ph. D., Pharm.D., D.Biol.Sci., Unit of Molecular Modelling, Faculty of Pharmacy, University of Navarra, Pamplona, Spain Hernán Garcia, Pharm.D., Garbil Pharma Investigación Chile, Santiago, Chile Christoph von der Goltz, M.D., University of Heidelberg, Dept. of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Mannheim, Germany James Haorah, Ph.D., Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA Andreas Heinz, M.D., Department of Psychiatry and Psychotherapy of the Charité - University Medical Center, Campus Charité Mitte, Berlin, Germany Susumu Higuchi, M.D., Ph.D., National Hospital Organization Kurihama Alcoholism Center, Yokosuka, Kanagawa, Japan George A. Kenna, Ph.D., R.Ph. Department of Psychiatry, Brown University, Providence, RI, and The Westerly Hospital, Westerly, RI, USA Falk Kiefer, M.D., University of Heidelberg, Dept. of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Mannheim, Germany Thorsten Kienast, M.D., Department of Psychiatry and Psychotherapy of the Charité - University Medical Center, Campus Charité Mitte, Berlin, Germany John H. Krystal, M.D., Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA Nita Makhija, Ed.M., Department of Psychiatry, Columbia University, and New York State Psychiatric Institute, New York, NY, USA Rosanna Mancinelli, Biol. Sci. D., Department of Environment and Primary Prevention, Istituto Superiore di Sanità, Roma, Italy Ann M. Manzardo, Ph.D., Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, Kansas City, KS, USA Ezio Manzato, M.D., Department of Addiction Medicine, Hospital "Chiarenzi" of Zevio, Verona, and Italian Society of Addiction Medicine (FeDerSerD), Milan, Italy Sachio Matsushita, M.D., National Hospital Organization Kurihama Alcoholism Center, Yokosuka, Kanagawa, Japan Milagros Méndez, Ph.D., Departamento de Neuroquímica, Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría Ramón de la Fuente, México D.F., México Jose Javier Miguel-Hidalgo, Ph.D., Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA Marcela Morales-Mulia, Ph.D., Departamento de Neuroquímica, Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría Ramón de la Fuente, México D.F., México Stephanie A. Morris, B.S., Department of Pharmaceutical Sciences, The University of Kentucky, Lexington, KY, USA Felice Nava, M.D., Department of Addiction Medicine, Hospital of Castelfranco Veneto, Treviso, and Italian Society of Addiction Medicine (FeDerSerD), Milan, Italy Kimberly Nixon, Ph.D., Department of Pharmaceutical Sciences, The University of Kentucky, Lexington, KY, USA Carlos Paeile, D.D.S., Garbil Pharma Investigación Chile, Santiago, Chile Elizabeth C. Penick, Ph.D., Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, Kansas City, KS, USA Yuri Persidsky M.D., Ph.D., Departments of Pharmacology and Experimental Neuroscience, and Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA Carmen Rasmussen, Ph.D., Department of Pediatrics, University of Alberta and Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada Sungwon Roh, M.D., Ph.D., National Hospital Organization Kurihama Alcoholism Center, Yokosuka, Kanagawa, Japan Gunter Schumann, M.D., Institute of Psychiatry, Kings College, London, UK Leo Sher, M.D., Department of Psychiatry, Columbia University, and New York State Psychiatric Institute, New York, NY, USA Peter J. Syapin, Ph.D., Alcohol and Brain Research Laboratory, Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA Roberta J. Ward, Ph.D., Biologie du Comportement, Université Catholique de Louvain, Louvain-la-Neuve, Belgium Philippe De Witte, Ph.D., Biologie du Comportement, Université Catholique de Louvain, Louvain-la-Neuve, Belgium Katy Wyper, B.Sc., Department of Pediatrics, University of Alberta and Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada
Publisher: Nova Science Publishers
Editor: Leo Sher, M.D.
Contributors:
Research on the Neurobiology of Alcohol Use Disorders